Search Results - "Schmid, Yasmin"

Refine Results
  1. 1

    LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality by Dolder, Patrick C, Schmid, Yasmin, Müller, Felix, Borgwardt, Stefan, Liechti, Matthias E

    Published in Neuropsychopharmacology (New York, N.Y.) (01-10-2016)
    “…Lysergic acid diethylamide (LSD) is used recreationally and has been evaluated as an adjunct to psychotherapy to treat anxiety in patients with…”
    Get full text
    Journal Article
  2. 2

    Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects by Schmid, Yasmin, Enzler, Florian, Gasser, Peter, Grouzmann, Eric, Preller, Katrin H, Vollenweider, Franz X, Brenneisen, Rudolf, Müller, Felix, Borgwardt, Stefan, Liechti, Matthias E

    Published in Biological psychiatry (1969) (15-10-2015)
    “…Abstract Background After no research in humans for >40 years, there is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric…”
    Get full text
    Journal Article
  3. 3

    Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects by Dolder, Patrick C., Müller, Felix, Schmid, Yasmin, Borgwardt, Stefan J., Liechti, Matthias E.

    Published in Psychopharmacology (01-02-2018)
    “…Rationale 3,4-Methylenedioxymethamphetamine (MDMA) is used recreationally and investigated as an adjunct to psychotherapy. Methylphenidate and modafinil are…”
    Get full text
    Journal Article
  4. 4

    Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis by Vizeli, Patrick, Straumann, Isabelle, Holze, Friederike, Schmid, Yasmin, Dolder, Patrick C., Liechti, Matthias E.

    Published in Scientific reports (25-05-2021)
    “…Lysergic acid diethylamide (LSD) is a classic psychedelic substance that is used recreationally and investigated in psychiatric research. There are no…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects by Klaiber, Aaron, Schmid, Yasmin, Becker, Anna M., Straumann, Isabelle, Erne, Livio, Jelusic, Alen, Thomann, Jan, Luethi, Dino, Liechti, Matthias E.

    Published in Translational psychiatry (30-09-2024)
    “…Classic psychedelics have regained interest in research and therapy. Despite the long tradition of the human use of mescaline, modern data on its…”
    Get full text
    Journal Article
  7. 7

    Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants by Vizeli, Patrick, Studerus, Erich, Holze, Friederike, Schmid, Yasmin, Dolder, Patrick C., Ley, Laura, Straumann, Isabelle, Becker, Anna M., Müller, Felix, Arikci, Denis, Liechti, Matthias E.

    Published in Translational psychiatry (04-09-2024)
    “…The pharmacodynamic effects of lysergic acid diethylamide (LSD) are diverse and different in different individuals. Effects of other psychoactive substances…”
    Get full text
    Journal Article
  8. 8

    Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distributions by Irene Scholz, Yasmin Schmid, Aristomenis K. Exadaktylos, Manuel Haschke, Matthias E. Liechti, Evangelia Liakoni

    Published in Swiss medical weekly (24-07-2019)
    “…AIMS OF THE STUDY To analyse emergency department (ED) presentations related to acute medical problems after recreational use of prescription/over-the-counter…”
    Get full text
    Journal Article
  9. 9

    Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing by Schmidt, André, Müller, Felix, Dolder, Patrick C, Schmid, Yasmin, Zanchi, Davide, Egloff, Laura, Liechti, Matthias E, Borgwardt, Stefan

    “…Abstract Background Stimulants such as methylphenidate and modafinil are frequently used as cognitive enhancers in healthy people, whereas…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans by Steuer, Andrea E, Schmidhauser, Corina, Tingelhoff, Eva H, Schmid, Yasmin, Rickli, Anna, Kraemer, Thomas, Liechti, Matthias E

    Published in PloS one (11-03-2016)
    “…3,4-methylenedioxymethamphetamine (MDMA; ecstasy) metabolism is known to be stereoselective, with preference for S-stereoisomers. Its major metabolic step…”
    Get full text
    Journal Article
  13. 13

    Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports by Brockhaus, Lisa, Schmid, Yasmin, Rast, Anna C, Rätz Bravo, Alexandra E, Hofmeier, Kathrin Scherer, Leuppi-Taegtmeyer, Anne B

    Published in BMC pharmacology & toxicology (12-02-2019)
    “…True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We…”
    Get full text
    Journal Article
  14. 14

    Long-lasting subjective effects of LSD in normal subjects by Schmid, Yasmin, Liechti, Matthias E.

    Published in Psychopharmacology (01-02-2018)
    “…Rationale Lysergic acid diethylamide (LSD) and other serotonergic hallucinogens can induce profound alterations of consciousness and mystical-type experiences,…”
    Get full text
    Journal Article
  15. 15

    Alterations of consciousness and mystical-type experiences after acute LSD in humans by Liechti, Matthias E., Dolder, Patrick C., Schmid, Yasmin

    Published in Psychopharmacology (01-05-2017)
    “…Rationale Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. Acute mystical-type experiences that are acutely induced by…”
    Get full text
    Journal Article
  16. 16

    Acute subjective effects in LSD- and MDMA-assisted psychotherapy by Schmid, Yasmin, Gasser, Peter, Oehen, Peter, Liechti, Matthias E

    Published in Journal of psychopharmacology (Oxford) (01-04-2021)
    “…Background: Lysergic acid diethylamide (LSD) and 3,4-methylenedioxymethamphetamine (MDMA) were used in psychotherapy in the 1960s–1980s, and are currently…”
    Get full text
    Journal Article
  17. 17

    Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases by Schipper, Sivan, Nigam, Kabir, Schmid, Yasmin, Piechotta, Vanessa, Ljuslin, Michael, Beaussant, Yvan, Schwarzer, Guido, Boehlke, Christopher

    Published in Cochrane database of systematic reviews (12-09-2024)
    “…Psychedelic-assisted therapy refers to a group of therapeutic practices involving psychedelics taken under therapeutic supervision from physicians,…”
    Get more information
    Journal Article
  18. 18

    Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants by Müller, Felix, Kraus, Elias, Holze, Friederike, Becker, Anna, Ley, Laura, Schmid, Yasmin, Vizeli, Patrick, Liechti, Matthias E., Borgwardt, Stefan

    Published in Psychopharmacology (01-06-2022)
    “…Background LSD and psilocybin are increasingly used in phase I trials and evaluated as therapeutic agents for mental disorders. The phenomenon of reoccurring…”
    Get full text
    Journal Article
  19. 19

    Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects by Dolder, Patrick C., Schmid, Yasmin, Steuer, Andrea E., Kraemer, Thomas, Rentsch, Katharina M., Hammann, Felix, Liechti, Matthias E.

    Published in Clinical pharmacokinetics (01-10-2017)
    “…Background and Objective Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. The aim of the present study was to characterize the…”
    Get full text
    Journal Article
  20. 20

    Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy by Schmid, Yasmin, Bershad, Anya K.

    “…There has been renewed interest in the use of 3,4-methylenedioxy-methamphetamine (MDMA) and serotonergic psychedelics in the treatment of multiple psychiatric…”
    Get full text
    Journal Article